BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3736329)

  • 1. Exogenous l-dopa alters spiroperidol binding, in vivo, in the mouse striatum.
    De Jesus OT; Van Moffaert GJ; Dinerstein RJ; Friedman AM
    Life Sci; 1986 Jul; 39(4):341-9. PubMed ID: 3736329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
    Csernansky JG; Friedhoff AJ; Bonnet KA
    Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243
    [No Abstract]   [Full Text] [Related]  

  • 3. The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats.
    Heikkila RE; Shapiro BS; Duvoisin RC
    Brain Res; 1981 May; 211(2):285-92. PubMed ID: 7237124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo binding of spiroperidol and bromospiroperidol at low drug loadings.
    DeJesus OT; Revenaugh JR; Dinerstein RJ; Friedman AM
    Life Sci; 1984 Nov; 35(21):2165-8. PubMed ID: 6493007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release.
    Nielsen EB; Nielsen M; Braestrup C
    Psychopharmacology (Berl); 1983; 81(1):81-5. PubMed ID: 6415736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
    Riffee WH; Wilcox RE; Vaughn DM; Smith RV
    Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding of [11C]spiroperidol in rat brain in vivo.
    Arnett CD; Fowler JS; Wolf AP; MacGregor RR
    J Neurochem; 1983 Feb; 40(2):455-9. PubMed ID: 6185638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic component of [3H]spiroperidol binding in the rat anterior cerebral cortex.
    Marchais D; Tassin JP; Bockaert J
    Brain Res; 1980 Feb; 183(1):235-40. PubMed ID: 7357406
    [No Abstract]   [Full Text] [Related]  

  • 9. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes.
    Howlett DR; Nahorski SR
    FEBS Lett; 1978 Mar; 87(1):152-6. PubMed ID: 631328
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro evidence of dopaminergic system down regulation induced by chronic L-DOPA.
    Ponzio F; Cimino M; Achilli G; Lipartiti M; Perego C; Vantini G; Algeri S
    Life Sci; 1984 May; 34(22):2107-16. PubMed ID: 6145075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermodynamic differences between agonist and antagonist interactions with binding sites for [3H]spiroperidol in rat striatum.
    Zahniser NR; Molinoff PB
    Mol Pharmacol; 1983 Mar; 23(2):303-9. PubMed ID: 6835199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of timiperone on 3H-spiroperidol binding to rat striatal dopamine receptors.
    Tachizawa H; Sudo K; Sano M
    Eur J Pharmacol; 1979 Nov; 59(3-4):245-51. PubMed ID: 43256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
    Neve KA; Altar CA; Wong CA; Marshall JF
    Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo 3H-spiroperidol binding to rat striatum and the inhibitory effects of neuroleptics.
    Nakajima T; Egawa E; Kuruma I
    Jpn J Pharmacol; 1981 Apr; 31(2):159-64. PubMed ID: 6118446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of chronic bromocriptine and L-dopa on spiperone binding and apomorphine-induced stereotypy.
    Globus M; Bannet J; Lerer B; Belmaker RH
    Psychopharmacology (Berl); 1982; 78(1):81-4. PubMed ID: 6815701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation by cations of [3H]spiroperidol binding associated with dopamine receptors of rat brain.
    Usdin TB; Creese I; Snyder SH
    J Neurochem; 1980 Mar; 34(3):669-76. PubMed ID: 6766497
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical alterations of dopamine receptor responses following chronic L-dopa therapy.
    Wilner KD; Butler IJ; Seifert WE; Clement-Cormier YC
    Biochem Pharmacol; 1980 Mar; 29(5):701-6. PubMed ID: 20227943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced [3H]spiroperidol binding in striatum of spontaneously hypertensive rat (SHR).
    Chiu P; Rajakumar G; Chiu S; Kwan CY; Mishra RK
    Eur J Pharmacol; 1982 Aug; 82(3-4):243-4. PubMed ID: 7128691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.